Uncategorized

Bernard Lown, MD, a renowned cardiologist who played a pivotal role in the development of the first reliable heart defibrillator, died Feb. 16, The New York Times reports. He was 99. 

Boston-based Dana-Farber Cancer Institute became the newest member of Caris Life Sciences' Precision Oncology Alliance Feb. 16. 

Ivabradine, a drug used for heart failure, improved symptoms associated with postural orthostatic tachycardia syndrome, a condition that causes rapid heart rate and lightheadedness, according to research published Feb. 15 in Journal of the American College of Cardiology.

A urine test that measures cancer-specific genes for prostate cancer could be an effective alternative to invasive biopsies, according to validation study results published in the March issue of the Journal of Urology.

Browns Mills, N.J.-based Deborah Heart and Lung Center has launched a post-COVID-19 recovery program, the center said Feb. 12. 

New Brunswick, N.J.-based Rutgers Cancer Institute named James Aikins Jr., MD, chief of gynecologic oncology. 

Breast cancer death rates have slightly increased in women younger than 40, reversing a longstanding trend in mortality rate decreases, according to research findings published Feb. 9 in Radiology.

As Cleveland Clinic celebrated its 100th anniversary, Brian Bolwell, MD, chair of its Taussig Cancer Institute, reflected on the advancements made in cancer care over the last 10 years in a recent statement published on the health system's website.

Nebraska Medicine recently became the first health system in the U.S. to implant a new type of cardiac stent.

The Dartmouth-Hitchcock Norris Cotton Cancer Center in Lebanon, N.H., has installed radiation vision cameras in its radiotherapy treatment rooms, allowing clinicians to see real-time video of the radiation treatment beam as it's directed on patients via a process known as…